⌘K

08:00:37·78d

SECFiling

Entera Bio Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

ENTX· Entera Bio Ltd.

Health Care

Original source

Companies

ENTX
Entera Bio Ltd.
Health Care

Related

PR3d
BriefCast Publishes Transcript: Entera Bio's Osteoporosis KOL Roundtable on EB613 - Oral Anabolic Tablet Opportunity
PR9d
Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613
PR17d
Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners
SEC20d
Entera Bio Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
PR21d
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
SEC27d
SEC Form 10-K filed by Entera Bio Ltd.
SEC27d
Entera Bio Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
PR27d
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates